Satellos Bioscience Inc. (MSLE) stock
MSLENasdaqPharmaceutical PreparationsFiscal year ends December 31
$5.94−0.26 (-4.19%)
Close on Nov 18, 2026Market cap $91.83MP/E –Yield –
Satellos Bioscience free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2025 it was -$23.60M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$23.60M | – |
| FY2024 | Dec 31, 2024 | -$18.26M | – |
See a number that looks wrong?